{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T09:48:17Z","timestamp":1768729697500,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM124661"],"award-info":[{"award-number":["R35GM124661"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R01GM143493"],"award-info":[{"award-number":["1R01GM143493"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.molpha.2025.100030","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T17:06:49Z","timestamp":1742404009000},"page":"100030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Discovery of RGS2-FBXO44 interaction inhibitors using a cell-based NanoBit assay"],"prefix":"10.1016","volume":"107","author":[{"given":"Sadikshya","family":"Aryal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6969-9780","authenticated-orcid":false,"given":"Cindy Shi Yee","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4191-8905","authenticated-orcid":false,"given":"Harrison J.","family":"McNabb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0925-1346","authenticated-orcid":false,"given":"Ahmad","family":"Junaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8724-1098","authenticated-orcid":false,"given":"Ryan A.","family":"Altman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1460-1045","authenticated-orcid":false,"given":"Benita","family":"Sj\u00f6gren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molpha.2025.100030_bib1","doi-asserted-by":"crossref","first-page":"21248","DOI":"10.1074\/jbc.M312407200","article-title":"RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq\/11alpha signaling","volume":"279","author":"Bernstein","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.molpha.2025.100030_bib2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/acschemneuro.5b00063","article-title":"Selectivity and anti-Parkinson's potential of thiadiazolidinone RGS4 inhibitors","volume":"6","author":"Blazer","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.molpha.2025.100030_bib3","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1021\/bi1019622","article-title":"A nanomolar-potency small molecule inhibitor of regulator of G-protein signaling proteins","volume":"50","author":"Blazer","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.molpha.2025.100030_bib4","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1124\/mol.106.029397","article-title":"N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells","volume":"71","author":"Bodenstein","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.molpha.2025.100030_bib5","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1074\/jbc.273.14.7795","article-title":"The cancer-predisposing mutation C61G disrupts homodimer formation in the NH2-terminal BRCA1 RING finger domain","volume":"273","author":"Brzovic","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.molpha.2025.100030_bib6","doi-asserted-by":"crossref","first-page":"41399","DOI":"10.1074\/jbc.M106551200","article-title":"BRCA1 RING domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions","volume":"276","author":"Brzovic","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.molpha.2025.100030_bib7","doi-asserted-by":"crossref","first-page":"22931","DOI":"10.1074\/jbc.M001605200","article-title":"RGS4 is arginylated and degraded by the N-end rule pathway in vitro","volume":"275","author":"Davydov","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.molpha.2025.100030_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/acschembio.5b00753","article-title":"NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells","volume":"11","author":"Dixon","year":"2016","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.molpha.2025.100030_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10555-017-9707-8","article-title":"The proteasome and proteasome inhibitors in multiple myeloma","volume":"36","author":"Gandolfi","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.molpha.2025.100030_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.molpha.2025.100030_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1172\/JCI15598","article-title":"Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice","volume":"111","author":"Heximer","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.molpha.2025.100030_bib12","doi-asserted-by":"crossref","first-page":"14389","DOI":"10.1073\/pnas.94.26.14389","article-title":"RGS2\/G0S8 is a selective inhibitor of Gqalpha function","volume":"94","author":"Heximer","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.molpha.2025.100030_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/bs.mie.2022.03.038","article-title":"Cellular thermal shift assay (CETSA) for determining the drug binding affinity using Ba\/F3 clones stably expressing receptor pseudokinases","volume":"667","author":"Karvonen","year":"2022","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.molpha.2025.100030_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12964-020-00552-7","article-title":"Regulators of G-protein signaling, RGS2 and RGS4, inhibit protease-activated receptor 4-mediated signaling by forming a complex with the receptor and Galpha in live cells","volume":"18","author":"Kim","year":"2020","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.molpha.2025.100030_bib15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1182\/blood-2005-12-5148","article-title":"Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia","volume":"108","author":"Kojima","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.molpha.2025.100030_bib16","doi-asserted-by":"crossref","first-page":"15030","DOI":"10.1073\/pnas.0507533102","article-title":"RGS4 and RGS5 are in vivo substrates of the N-end rule pathway","volume":"102","author":"Lee","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molpha.2025.100030_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.molcel.2011.05.034","article-title":"Alternative ubiquitin activation\/conjugation cascades interact with N-end rule ubiquitin ligases to control degradation of RGS proteins","volume":"43","author":"Lee","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.molpha.2025.100030_bib18","doi-asserted-by":"crossref","first-page":"41014","DOI":"10.1074\/jbc.M112.407106","article-title":"The F-box protein FBXO44 mediates BRCA1 ubiquitination and degradation","volume":"287","author":"Lu","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.molpha.2025.100030_bib19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cellsig.2011.01.023","article-title":"Potent and selective inhibition of angiotensin AT1 receptor signaling by RGS2: roles of its N-terminal domain","volume":"23","author":"Matsuzaki","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.molpha.2025.100030_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/molpharm.120.000061","article-title":"N-terminal targeting of regulator of G protein signaling protein 2 for F-box only protein 44-mediated proteasomal degradation","volume":"98","author":"McNabb","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.molpha.2025.100030_bib21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1083\/jcb.200811058","article-title":"Translational control by RGS2","volume":"186","author":"Nguyen","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.molpha.2025.100030_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ab.2007.04.007","article-title":"A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers","volume":"366","author":"Niles","year":"2007","journal-title":"Anal Biochem"},{"key":"10.1016\/j.molpha.2025.100030_bib23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1124\/mol.114.092403","article-title":"Identification of protein kinase C activation as a novel mechanism for RGS2 protein upregulation through phenotypic screening of natural product extracts","volume":"86","author":"Raveh","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.molpha.2025.100030_bib24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1146\/annurev.biochem.69.1.795","article-title":"GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins","volume":"69","author":"Ross","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.molpha.2025.100030_bib25","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.cellsig.2005.05.004","article-title":"RGS2 interacts with Gs and adenylyl cyclase in living cells","volume":"18","author":"Roy","year":"2006","journal-title":"Cell Signal"},{"key":"10.1016\/j.molpha.2025.100030_bib26","doi-asserted-by":"crossref","first-page":"15842","DOI":"10.1074\/jbc.M210663200","article-title":"Identification of RGS2 and type V adenylyl cyclase interaction sites","volume":"278","author":"Salim","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.molpha.2025.100030_bib27","series-title":"Schr\u00f6dinger Release 2021-1: Maestro","year":"2024"},{"key":"10.1016\/j.molpha.2025.100030_bib28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/acschembio.7b00549","article-title":"CRISPR-mediated tagging of endogenous proteins with a luminescent peptide","volume":"13","author":"Schwinn","year":"2018","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.molpha.2025.100030_bib29","doi-asserted-by":"crossref","first-page":"12984","DOI":"10.1073\/pnas.1304045110","article-title":"Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery","volume":"110","author":"Silvestre","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.molpha.2025.100030_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bph.13716","article-title":"The evolution of regulators of G protein signalling proteins as drug targets - 20 years in the making: IUPHAR Review 21","volume":"174","author":"Sj\u00f6gren","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molpha.2025.100030_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1877-1173(10)91004-1","article-title":"Regulators of G protein signaling proteins as targets for drug discovery","volume":"91","author":"Sj\u00f6gren","year":"2010","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.molpha.2025.100030_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/jpet.115.231571","article-title":"Digoxin-mediated upregulation of RGS2 protein protects against cardiac injury","volume":"357","author":"Sj\u00f6gren","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.molpha.2025.100030_bib33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1124\/mol.112.079293","article-title":"Cardiotonic steroids stabilize regulator of G protein signaling 2 protein levels","volume":"82","author":"Sj\u00f6gren","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.molpha.2025.100030_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123581","article-title":"FBXO44-mediated degradation of RGS2 protein uniquely depends on a cullin 4B\/DDB1 complex","volume":"10","author":"Sj\u00f6gren","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molpha.2025.100030_bib35","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1016\/j.cellsig.2013.09.007","article-title":"Reversible inhibitors of regulators of G-protein signaling identified in a high-throughput cell-based calcium signaling assay","volume":"25","author":"Storaska","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.molpha.2025.100030_bib36","first-page":"408","article-title":"Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice","volume":"119","author":"Takimoto","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.molpha.2025.100030_bib37","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng0495-444","article-title":"Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression","volume":"9","author":"Thompson","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.molpha.2025.100030_bib38","first-page":"547","article-title":"Deregulation of RGS2 in cardiovascular diseases","volume":"2","author":"Tsang","year":"2010","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.molpha.2025.100030_bib39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/ml200263y","article-title":"Small molecule inhibitors of regulator of G protein signalling (RGS) proteins","volume":"3","author":"Turner","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.molpha.2025.100030_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25152905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25152905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:52:09Z","timestamp":1762213929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X25152905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0026895X25152905"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100030","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of RGS2-FBXO44 interaction inhibitors using a cell-based NanoBit assay","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100030"}}